Artal Group as of Sept. 30, 2019
Portfolio Holdings for Artal Group
Artal Group holds 97 positions in its portfolio as reported in the September 2019 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Ww Intl (WW) | 22.5 | $560M | 15M | 37.82 | |
Lexicon Pharmaceuticals Com New (LXRX) | 7.3 | $181M | 60M | 3.01 | |
Bristol Myers Squibb Call Option (BMY) | 7.1 | $178M | 3.5M | 50.71 | |
Alibaba Group Hldg Sponsored Ads (BABA) | 3.7 | $92M | 550k | 167.23 | |
Avantor (AVTR) | 3.5 | $88M | 6.0M | 14.70 | |
Bank of America Corporation Call Option (BAC) | 3.5 | $88M | 3.0M | 29.17 | |
Moderna Call Option (MRNA) | 3.3 | $81M | 5.1M | 15.92 | |
Beigene Sponsored Adr (BGNE) | 3.2 | $80M | 650k | 122.46 | |
Medicines Company | 2.8 | $70M | 1.4M | 50.00 | |
Morgan Stanley Com New Call Option (MS) | 2.6 | $64M | 1.5M | 42.67 | |
Acceleron Pharma | 2.4 | $59M | 1.5M | 39.51 | |
Alnylam Pharmaceuticals (ALNY) | 2.3 | $56M | 700k | 80.42 | |
Blueprint Medicines (BPMC) | 1.8 | $44M | 600k | 73.47 | |
NVIDIA Corporation (NVDA) | 1.4 | $35M | 200k | 174.07 | |
Morphic Hldg (MORF) | 1.3 | $33M | 1.8M | 18.11 | |
Fate Therapeutics (FATE) | 1.2 | $31M | 2.0M | 15.53 | |
Gossamer Bio (GOSS) | 1.1 | $27M | 1.6M | 16.79 | |
Amicus Therapeutics (FOLD) | 1.0 | $24M | 3.0M | 8.02 | |
Argenx Se Sponsored Adr (ARGX) | 0.9 | $23M | 200k | 113.96 | |
Rubius Therapeutics | 0.9 | $22M | 2.8M | 7.85 | |
Atara Biotherapeutics (ATRA) | 0.8 | $21M | 1.5M | 14.12 | |
Sage Therapeutics (SAGE) | 0.8 | $21M | 150k | 140.29 | |
Scholar Rock Hldg Corp (SRRK) | 0.8 | $21M | 2.3M | 8.95 | |
Nektar Therapeutics (NKTR) | 0.8 | $20M | 1.1M | 18.22 | |
Zillow Group Cl C Cap Stk (Z) | 0.8 | $19M | 650k | 29.82 | |
Spdr Series Trust S&p Biotech Call Option (XBI) | 0.8 | $19M | 250k | 76.25 | |
Incyte Corporation Call Option (INCY) | 0.7 | $19M | 250k | 74.23 | |
Solid Biosciences | 0.7 | $18M | 1.7M | 10.34 | |
Global Blood Therapeutics In | 0.7 | $17M | 350k | 48.52 | |
Deciphera Pharmaceuticals (DCPH) | 0.7 | $17M | 500k | 33.94 | |
Cyclerion Therapeutics | 0.7 | $17M | 1.4M | 12.12 | |
Mirati Therapeutics | 0.6 | $16M | 200k | 77.91 | |
Epizyme | 0.6 | $16M | 1.5M | 10.32 | |
Uber Technologies (UBER) | 0.6 | $15M | 500k | 30.47 | |
Turning Point Therapeutics I | 0.6 | $15M | 400k | 37.60 | |
Ascendis Pharma A S Sponsored Adr (ASND) | 0.6 | $14M | 150k | 96.32 | |
Dicerna Pharmaceuticals | 0.6 | $14M | 1.0M | 14.36 | |
American Airls Call Option (AAL) | 0.5 | $14M | 500k | 26.97 | |
Agios Pharmaceuticals (AGIO) | 0.5 | $13M | 400k | 32.40 | |
Iovance Biotherapeutics (IOVA) | 0.5 | $13M | 700k | 18.20 | |
Realreal (REAL) | 0.5 | $13M | 565k | 22.36 | |
Tricida | 0.4 | $11M | 360k | 30.87 | |
Stoneco Com Cl A (STNE) | 0.4 | $10M | 300k | 34.78 | |
Y Mabs Therapeutics (YMAB) | 0.4 | $10M | 400k | 26.06 | |
Xencor (XNCR) | 0.4 | $10M | 300k | 33.73 | |
Delphi Technologies SHS Call Option | 0.4 | $10M | 750k | 13.40 | |
Fidelity National Information Services (FIS) | 0.4 | $10M | 75k | 132.76 | |
Audentes Therapeutics | 0.4 | $9.8M | 350k | 28.09 | |
Accelr8 Technology | 0.4 | $9.3M | 500k | 18.57 | |
Bluebird Bio (BLUE) | 0.4 | $9.2M | 100k | 91.82 | |
Albireo Pharma | 0.4 | $9.0M | 450k | 20.00 | |
Merus N V (MRUS) | 0.4 | $8.9M | 500k | 17.82 | |
Hookipa Pharma Inc equity (HOOK) | 0.3 | $8.5M | 1.1M | 7.50 | |
Replimune Group (REPL) | 0.3 | $8.3M | 600k | 13.90 | |
Minerva Neurosciences | 0.3 | $7.8M | 1.0M | 7.75 | |
Proqr Thrapeutics N V Shs Euro (PRQR) | 0.3 | $7.5M | 1.3M | 5.76 | |
Translate Bio | 0.3 | $7.4M | 750k | 9.91 | |
Tcr2 Therapeutics Inc cs | 0.3 | $7.1M | 472k | 15.03 | |
Kaleido Biosciences Ord (KLDO) | 0.3 | $6.8M | 901k | 7.53 | |
Springworks Therapeutics (SWTX) | 0.3 | $6.7M | 309k | 21.68 | |
Fibrogen (FGEN) | 0.3 | $6.7M | 180k | 36.98 | |
Agenus Com New (AGEN) | 0.3 | $6.5M | 2.5M | 2.58 | |
Autolus Therapeutics Sponsored Ads (AUTL) | 0.2 | $6.2M | 500k | 12.42 | |
Denali Therapeutics (DNLI) | 0.2 | $6.1M | 400k | 15.32 | |
ArQule | 0.2 | $6.1M | 850k | 7.17 | |
Nio Sponsored Ads (NIO) | 0.2 | $5.9M | 3.8M | 1.56 | |
Spero Therapeutics (SPRO) | 0.2 | $5.7M | 540k | 10.60 | |
Krystal Biotech (KRYS) | 0.2 | $5.2M | 150k | 34.73 | |
Regenxbio Inc equity us cm (RGNX) | 0.2 | $5.2M | 145k | 35.60 | |
Tg Therapeutics (TGTX) | 0.2 | $5.1M | 900k | 5.62 | |
Ac Immune Sa SHS (ACIU) | 0.2 | $5.0M | 1.0M | 4.95 | |
Adaptive Biotechnologies Cor (ADPT) | 0.2 | $4.6M | 150k | 30.90 | |
Lions Gate Entmnt Corp Cl A Vtg Call Option (LGF.A) | 0.2 | $4.6M | 500k | 9.25 | |
Restorbio | 0.2 | $4.4M | 500k | 8.84 | |
Bridgebio Pharma (BBIO) | 0.2 | $4.3M | 200k | 21.47 | |
Orchard Therapeutics Ads | 0.2 | $4.2M | 350k | 11.88 | |
Kura Oncology (KURA) | 0.2 | $3.8M | 250k | 15.17 | |
D Stemline Therapeutics | 0.2 | $3.7M | 360k | 10.41 | |
Selecta Biosciences (RNAC) | 0.1 | $3.7M | 2.1M | 1.75 | |
Sangamo Biosciences (SGMO) | 0.1 | $3.7M | 405k | 9.05 | |
Igm Biosciences (IGMS) | 0.1 | $3.6M | 200k | 17.75 | |
Douyu International Hldngs L Sponsored Ads | 0.1 | $3.3M | 400k | 8.19 | |
Alector (ALEC) | 0.1 | $3.2M | 225k | 14.42 | |
111 Ads (YI) | 0.1 | $3.2M | 650k | 4.87 | |
Aravive | 0.1 | $3.0M | 400k | 7.50 | |
Allogene Therapeutics (ALLO) | 0.1 | $2.7M | 100k | 27.26 | |
Axcella Health Inc equity | 0.1 | $2.5M | 450k | 5.66 | |
Viking Therapeutics (VKTX) | 0.1 | $2.4M | 350k | 6.88 | |
Twist Bioscience Corp (TWST) | 0.1 | $2.4M | 100k | 23.88 | |
Aeglea Biotherapeutics | 0.1 | $2.3M | 300k | 7.69 | |
Gritstone Oncology Ord (GRTS) | 0.1 | $2.2M | 250k | 8.64 | |
Clovis Oncology | 0.1 | $2.0M | 500k | 3.93 | |
Square Cl A (SQ) | 0.1 | $1.9M | 30k | 61.97 | |
Akebia Therapeutics (AKBA) | 0.1 | $1.7M | 425k | 3.92 | |
Aduro Biotech | 0.0 | $1.1M | 1.0M | 1.06 | |
Ironwood Pharmaceuticals Com Cl A (IRWD) | 0.0 | $949k | 111k | 8.59 | |
Avrobio Ord (AVRO) | 0.0 | $331k | 23k | 14.12 |